Drug companies are warning that pricing reform spells doom. Don't fall for it

Drug companies are warning that pricing reform spells doom. Don't fall for it

Democrats are on the verge of passing legislation that, among other things, would empower the government to directly negotiate the price Medicare pays for a handful of the costliest prescription drugs. We analyzed pricing practices and R&D productivity for 17 of the world's largest pharmaceutical companies, including Pfizer, AbbVie, Novartis and Johnson&…